STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Sees Significant Increase in Short Interest

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,500 shares, a growth of 48.6% from the October 15th total of 3,700 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 12,500 shares, the short-interest ratio is presently 0.4 days.

STRATA Skin Sciences Price Performance

NASDAQ SSKN traded down $0.09 on Friday, reaching $3.01. 5,058 shares of the stock traded hands, compared to its average volume of 12,246. STRATA Skin Sciences has a 12 month low of $2.51 and a 12 month high of $6.96. The company has a market cap of $12.55 million, a price-to-earnings ratio of -1.13 and a beta of 1.32. The firm’s fifty day simple moving average is $3.01 and its 200 day simple moving average is $3.24. The company has a quick ratio of 0.92, a current ratio of 1.14 and a debt-to-equity ratio of 1.59.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) EPS for the quarter. STRATA Skin Sciences had a negative return on equity of 67.36% and a negative net margin of 28.72%. The business had revenue of $8.44 million during the quarter. As a group, research analysts predict that STRATA Skin Sciences will post -1 EPS for the current fiscal year.

Hedge Funds Weigh In On STRATA Skin Sciences

An institutional investor recently bought a new position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV bought a new position in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned approximately 0.34% of STRATA Skin Sciences as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 32.43% of the company’s stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.